07-10-2022-0838 - Surgeon General & OIG at compilation 06-22-2022-0117

Wednesday, June 22, 2022

06-22-2022-0117 - can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..

Gamma-hydroxybutyrate (GHB, also known as sodium oxybate) has been found to be effective at reducing the number of cataplexy episodes.[18][19] Sodium oxybate is generally safe [19] and is typically the recommended treatment.[20]
Sodium oxybate (GHB) is a natural metabolite of GABA. Its main target is the dopaminergic system because at pharmacological concentration it acts as an agonist and modulates the dopamine neurotransmitters and dopaminergic signalling.[17] GHB was used to treat narcolepsy and cataplexy for more than 15 years[4] and it is the only drug authorised by the EMA to treat the whole disease in adults, and by the FDA to treat patients who suffer from cataplexy with the indication to be used for combating excessive daytime sleepiness.[20] This drug helps to normalise the sleep architecture, pushing the REM sleep toward its normal setting, and inhibits the intrusion during the day of its elements like the paralysis in cataplexy.[4]
https://en.wikipedia.org/wiki/Cataplexy

Note. GHB causes serious side effects. do not use glutamine, fat vars, waxes, palming drugs, protein var, antipsychots, steroids, genotox, hormones, waste, CL1 chem vars, etc.. can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..
https://en.wikipedia.org/wiki/NMDA_receptor_antagonist

By Nikiya Anton Bettey at June 22, 2022

Check out this site https://www.hhs.gov/surgeongeneral/index.html

[FRAUD IN MEDICINE AND COMP-BODY-UNIT-PROC DETAINER-OPERATIONS FOR VAR AT USA NAC DOM (PSYCHIATRY PSYCHOLOGY MEDICAL ETC.), CONTROL/CAUSE/MODULUS /AXIS/CENTER/COR/CENTER OF OPERATIONS/ETC. ALL USA ISSUES SHUNTED THROUGH THE CHANNEL TO DISTORTION WARP DISSIPATION DECAY DEPRECANS;; Reference Holy Bible DSM Diagnostic Statistical Manual Mental Disorder Varieties etc.. No obsolete text permitted including Freud or Research or Grayden-DSM or Personal (i.e. entity army etc.) or etc., where it concerns general populace including no radical ideology or terrorist ideology permitted as practice of medicine should be impost. Psuedoscientist is field discipline evident at USA NAC DOM; none else. Real scientist long time train work on progeny never lie cheat steal.]. SINGULAR PATHWAY IS NOT STATED OBJECTIVE OF DSM PSYCHIATRY AND ALL OF DISCIPLINE SHARE COMMON PURPOSE STATEMENT OBJECTIVE, ESPECIALLY FOR FEDERAL STATE LOCAL FUND.

can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..



Nikiya Anton Bettey

To:
DHS-OIG.OfficeofLegislativeAffairs@oig.dhs.gov

Sun 7/10/2022 6:26 PM

Wednesday, June 22, 2022

06-22-2022-0117 - can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..

Gamma-hydroxybutyrate (GHB, also known as sodium oxybate) has been found to be effective at reducing the number of cataplexy episodes.[18][19] Sodium oxybate is generally safe [19] and is typically the recommended treatment.[20]

Sodium oxybate (GHB) is a natural metabolite of GABA. Its main target is the dopaminergic system because at pharmacological concentration it acts as an agonist and modulates the dopamine neurotransmitters and dopaminergic signalling.[17] GHB was used to treat narcolepsy and cataplexy for more than 15 years[4] and it is the only drug authorised by the EMA to treat the whole disease in adults, and by the FDA to treat patients who suffer from cataplexy with the indication to be used for combating excessive daytime sleepiness.[20] This drug helps to normalise the sleep architecture, pushing the REM sleep toward its normal setting, and inhibits the intrusion during the day of its elements like the paralysis in cataplexy.[4]

https://en.wikipedia.org/wiki/Cataplexy

Note. GHB causes serious side effects. do not use glutamine, fat vars, waxes, palming drugs, protein var, antipsychots, steroids, genotox, hormones, waste, CL1 chem vars, etc.. can exacerbate disease facilitate environment for decay process and minor splitting desynchronization of decay process general. not individual diseases, symptom list, sign list, component nominer, disorders, schizophrenia, genetic disease, etc..

https://en.wikipedia.org/wiki/NMDA_receptor_antagonist

By Nikiya Anton Bettey at June 22, 2022

Singular Form